As veterans with PTSD continue to die by suicide, FDA demands do-over for MDMA trials
Flying in the face of stats from the U.S. Department of Veterans Affairs that say veterans continue to commit suicide at higher rates than non-veterans, the U.S. Food and Drug Administration last week declined to approve MDMA, a psychedelic compound, as a treatment for post-traumatic stress disorder.